VEGFA and hepatocellular carcinoma: We further examined the clinical relevance of these two subtypes of TAMs in two additional HCC cohorts and found that higher abundance of MMP9+ TAMs in tumors is strongly associated with worse overall survival (Fig. 3b and Supplementary Fig. 6e), as compared to a weak association of VEGFA+ TAMs (Supplementary Fig. 6f).